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Introduction {#sec001}
============

*Burkholderia cenocepacia* J2315 is a member of the *Burkholderia cepacia* complex (BCC), a group of aerobic Gram-negative beta-proteobacteria which mainly live in the rhizosphere, but can also act as opportunistic pathogens, particularly in individuals with cystic fibrosis \[[@pone.0236405.ref001]\].

Iron is essential for living organisms, as part of the catalytic/active site of many enzymes, yet it is mostly inaccessible for bacteria due to the low solubility under oxic conditions at neutral pH \[[@pone.0236405.ref002], [@pone.0236405.ref003]\]. Iron acquisition mechanisms are therefore important for survival of bacteria \[[@pone.0236405.ref004]\], as well as mechanisms to conserve iron under conditions of iron depletion. On the other hand, higher intracellular concentrations of iron are toxic to cells \[[@pone.0236405.ref003]\]. Free iron can react with the superoxide anion and with H~2~O~2~, natural by-products of respiration and oxidase reactions, to form the very reactive hydroxyl radical via the Fenton reaction. All reactive oxygen species (ROS) can damage DNA, proteins and lipids, and an excess of ROS leads to cell death. For protection against ROS, cells produce detoxifying enzymes such as catalases and superoxide dismutases (SOD) \[[@pone.0236405.ref003]\].

The ferric uptake regulator (Fur) is important for iron homeostasis in many bacteria. Its best known mechanism of action is the repression of genes involved in iron uptake under iron replete conditions by iron-dependent binding to a specific sequence motif, the Fur box \[[@pone.0236405.ref002]\]. In *Escherichia coli* and *Pseudomonas aeruginosa* Fur also positively regulates SOD, the iron scavenger protein bacterioferritin and several enzymes of the tricarboxylic acid cycle (TCA) \[[@pone.0236405.ref005], [@pone.0236405.ref006]\]. This positive regulation was attributed to indirect effects mediated by Fur-regulated small RNAs (sRNAs), RyhB in *E*. *coli* \[[@pone.0236405.ref006]\] and PrrF in *P*. *aeruginosa* \[[@pone.0236405.ref005]\]. Under iron-depletion the Fur repression of these sRNAs is lifted, they bind to the mRNA of their targets and the sRNA-mRNA hybrid is then rapidly degraded, or the translation of targets is inhibited \[[@pone.0236405.ref007]\]. This reduces the demand for iron in the cell, since many targets have iron or iron-sulfur clusters as cofactor.

A small RNA highly upregulated under iron depletion was identified in *B*. *cenocepacia* J2315 by screening dRNA-Seq data for short transcripts \[[@pone.0236405.ref008], [@pone.0236405.ref009]\] and designated ncS63. Its computationally predicted targets included confirmed targets of *E*. *coli* RyhB and *P*. *aeruginosa* PrrF, such as *sdhC* and *sodB* \[[@pone.0236405.ref005], [@pone.0236405.ref006], [@pone.0236405.ref010], [@pone.0236405.ref011]\], yet ncS63 has no sequence similarity to any known Fur-regulated sRNAs. Here we report on the full characterisation of this low iron-induced sRNA. As our results suggest that *B*. *cenocepacia* ncS63 shows analogy to RyhB and PrrF, we suggest the name BrrF ([*B*]{.ul}*urkholderia* [r]{.ul}egulatory [R]{.ul}NA involving iron, [F]{.ul}e), analogous to *P*. *aeruginosa* PrrF \[[@pone.0236405.ref005]\] and *Neisseria meningitidis* NrrF \[[@pone.0236405.ref012]\].

Materials and methods {#sec002}
=====================

Media {#sec003}
-----

Strains were routinely cultured in LB broth or agar (low-salt Lennox formulation: 10 g/L tryptone, 5 g/L yeast extract, 5 g/L NaCl, 1.5% agar), supplemented with 600 μg/ml trimethoprim (TP) as selective antibiotic where appropriate. Gene expression from the plasmid was induced by adding rhamnose (Sigma) to a final concentration of 0.2% (w/v). Iron depletion was induced by adding the iron chelator 2,2'-dipyridyl (Sigma) at 200 μM final concentration to LB broth or agar.

For growth curves on single carbon compounds, a phosphate buffered mineral medium (basal salt medium, BSM) was used; which contained 18.6 mM K~2~HPO~4~, 7.2 mM NaH~2~PO~4~, 37.4 mM NH~4~Cl, 0.1 g/L nitrilotriacetic acid, 0.2 g/L MgSO~4~ x 7 H~2~O, 0.012 g/L FeSO~4~ x 7 H~2~O, 0.003 g/L MnSO~4~ x H~2~O, 0.003 g/L ZnSO~4~ x 7 H~2~O, 0.001 g/L CoSO~4~ x 7 H~2~O, \[[@pone.0236405.ref013]\]. As *B*. *cenocepacia* J2315 does not grow in BSM when iron is depleted by addition of dipyridyl or by treating the medium with Chelex, low iron conditions were obtained by omitting iron sulfate.

All incubations were performed at 37°C.

Strains and plasmids {#sec004}
--------------------

*B*. *cenocepacia* strain J2315 ([S1 Table](#pone.0236405.s005){ref-type="supplementary-material"}) was used as background for all experiments. A *brrF* deletion mutant was constructed by allelic recombination as described by Aubert et al. \[[@pone.0236405.ref014]\]. Deletion of *brrF* was confirmed by Sanger sequencing of a 449 nt long region spanning *brrF*. Amplification of all inserts was performed with the HotStar HiFidelity Polymerase Kit (Qiagen).

For overexpressing BrrF, a region ranging from 80 nt upstream of the putative processing site to 49 nt downstream of the computationally predicted terminator sequence was amplified and cloned into an overexpression vector with a rhamnose-inducible promoter \[[@pone.0236405.ref015]\], yielding pBrrF-d1. The overexpression vector had previously been modified to remove the ribosome binding site and start codons \[[@pone.0236405.ref016]\].

The transcript expressed from pBrrF-d1 needs to be processed/cleaved to produce the native BrrF. Most computationally predicted interactions with targets were located at the very 5'end of the cleaved transcript, making it the most interesting region to introduce point mutations for complementation experiments. Introducing mutations so close to the cleavage site could potentially interfere with the processing of the overexpression transcript. For this reason, a second overexpression vector was constructed by inverse PCR with pBrrF-d1 as template, removing the sequences upstream of the putative processing site, and yielding pBrrF-d2. In the same manner, a vector carrying a *brrF* derivative with point mutations at position 8 and 9 was constructed, also by inverse PCR with pBrrF-d1 as template, yielding pBrrF-d3.

Overexpression plasmid derivatives were created by inverse PCR with the LongRange PCR kit (Qiagen). PCR products were digested with DpnI (Promega) to remove template plasmid, blunted with T4 DNA polymerase (Promega) to remove A-overhangs and gel-cleaned. Amplified plasmid was then phosphorylated using T4 polynucleotide kinase (Promega) and self-ligated (T4 DNA ligase, Promega). All plasmid inserts were verified by Sanger sequencing. Plasmids were transformed into *B*. *cenocepacia* J2315 by triparental mating and expression of BrrF from the plasmid in the presence of rhamnose was confirmed by qPCR.

All primer sequences are listed in [S2 Table](#pone.0236405.s006){ref-type="supplementary-material"}.

Growth curves {#sec005}
-------------

Growth on single carbon sources was measured in round-bottom 96-well microtiter plates (SPL Life Sciences) in a temperature-controlled microplate reader (Envision, Perkin Elmer), with intermittent shaking. Cells were inoculated at 10^6^ CFU/ml and optical density (O.D.) was measured at 30 min intervals over \>60 hours. The mineral medium was supplemented with 0.05% yeast extract and 0.05% casamino acids, without which strain J2315 would grow extremely slowly on only one carbon source. Controls with only the organic supplements were run on every plate. Compounds were purchased from Sigma-Aldrich, Fluka, Janssen, and Acros Organics. Every compound was tested in at least two independent biological replicates.

Growth in LB broth was investigated using glass flasks in a shaking incubator. Growth was monitored via backscattered light every 2 min using a Cell Growth Quantifier (CGQ, Aquila Biolabs).

Growth rates were determined using the equation μ \* h^-1^ = ln (x~t2~/x~t1~)/(t~2~-t~1~), where x denotes optical density or backscatter arbitrary units, and t~1~ and t~2~ refer to a point at the beginning or end of the analysed time interval, respectively \[[@pone.0236405.ref017]\]. The obtained values for μ of the biological replicates were then analysed either by One-way ANOVA or a two-tailed Student's t-test using SPSS (v. 25).

Sensitivity to H~2~O~2~ {#sec006}
-----------------------

Cell suspensions with an O.D. (595 nm) of 0.1 (approx. 10^8^ colony forming units (CFU) per ml) were spread on low-nutrient LB agar plates (1 g/L tryptone, 0.5 g/L yeast extract, 5 g/L NaCl, 1.5% agar) with a sterile cotton swab. Inoculated plates were pre-incubated for 1 hour to allow gene expression to start. Then, 10 μl of a 1% H~2~O~2~ (Sigma) solution were applied to 6 mm blank susceptibility testing discs (Oxoid) which were placed into the middle of the agar plate. Tests were performed in six replicates, on three different days, and growth inhibition zones were measured after 24 h incubation.

Superoxide dismutase activity measurements {#sec007}
------------------------------------------

SOD activity was determined with a SOD assay kit (Sigma 19160-1KT-F), which uses a water soluble tetrazolium salt that reacts with superoxide produced by a xanthine oxidase. SOD inhibits this reaction by removing the superoxide. Cells were grown in 25 ml LB broth in flasks on a shaker as described above, without addition of inducers, to an O.D. of 0.5 (5 x 10^8^ CFU/ml). Then the inducer was added and incubation continued for another hour (pulse expression). Cultures were then cooled in ice water and centrifuged at 4°C. The cells were washed twice in 25 ml 50 mM ice-cold sodium phosphate buffer, pH 7, re-suspended in 1 ml of the phosphate buffer supplemented with 1 mg/ml dithiothreitol, and centrifuged again. The supernatant was removed and the cell pellet stored at -80°C for a maximum of 24 hours. Cells were lysed in 1 ml ice cold phosphate buffer by bead beating with zirconia-silica beads (0.1 mm diameter, BioSpec). The lysate was centrifuged at max speed for 5 min at 4°C, the supernatant transferred into a fresh tube and kept on ice. The SOD assay was performed immediately according to the manufacturer's instructions. The protein concentration in the extract was determined with a Bradford assay (Sigma) and used for normalisation of the SOD activity.

Aconitase activity measurements {#sec008}
-------------------------------

Aconitase activity was determined by measuring the production of *cis*-aconitate. To this end isocitrate was added to a crude cell extract in the presence of high concentrations of citrate and the increase of absorbance at 240 nm was measured \[[@pone.0236405.ref018]--[@pone.0236405.ref020]\].

Cells were grown in flasks as mentioned for SOD activity measurements. After harvest (as above), cell were washed twice in a TRIS/citrate buffer (20 mM citric acid, 20 g/L TRIS, pH 8), resuspended in 1 ml ice cold TRIS/citrate buffer and immediately lysed by bead beating. The lysate was centrifuged and the supernatant kept on ice. For aconitase activation, freshly prepared cysteine and ammonium iron (II) sulfate solutions were subsequently added to a final concentration of 5 and 0.5 mM, respectively. Supplemented lysates were then incubated on ice for one hour before measurements.

DL-isocitrate (Na~3~-salt, Sigma) was added to the extract to a final concentration of 40 mM, at room temperature in a Biodrop μLite spectrophotometer, with a microvolume sample port of 0.5 mm path length. The absorbance at 240 nm was measured in intervals of 5 seconds for a total of 5 min and corrected for absorbance of the same sample without isocitrate addition. The protein concentration in the extract was determined with a Bradford assay, and a standard curve was generated with *cis*-aconitate (Sigma) added to heat-inactivated lysates (supplemented lysates heated to 50°C for 15 min and centrifuged) containing 40 mM isocitrate.

qPCR {#sec009}
----

Cells were grown in 25 ml LB broth in flasks on a shaker as described above. Rhamnose and/or dipyridyl were added 30 min before flasks were cooled in ice water and 4 ml culture harvested by centrifugation in microcentrifuge tubes at 4°C and maximum speed. This "pulse-expression" method was chosen to minimise secondary effects of iron depletion or BrrF-overexpression on target gene expression. Pellets were stored at -80°C for a maximum of one week. RNA was extracted with the RiboPure bacteria kit (ThermoFisher) with the following changes to the manufacturer's instructions: the crude extract was mixed with 1.25 x volumes ethanol before column cleaning to better retain sRNAs, and DNase I treatment time was increased to 60 min. RNA was transcribed to cDNA with the High Capacity cDNA RT kit (Applied Biosystems). qPCR was performed as described before \[[@pone.0236405.ref009]\], using the GoTaq qPCR Master Mix (Promega). Each reaction was run with two technical replicates, each condition with 3 biological replicates and a no-RT control, and no-template controls were performed for each gene. Cq values were normalised to control gene *rpoD* (BCAM0918). One-Way ANOVA with a Tukey Post-hoc test using SPSS (v. 25) was performed to determine statistical significance. All primer sequences are listed in [S2 Table](#pone.0236405.s006){ref-type="supplementary-material"}.

Computational methods {#sec010}
---------------------

To identify loci with Fur boxes in the *B*. *cenocepacia* J2315 genome, and to predict the Fur box consensus sequence, a two-step procedure was employed. Fur box-containing upstream sequences of *B*. *multivorans* \[[@pone.0236405.ref021]\] were analysed using the MEME tool \[[@pone.0236405.ref022]\] and the resulting motif was submitted to FIMO \[[@pone.0236405.ref022]\] to identify Fur box-containing upstream sequences of genes induced under iron-depleted conditions according to a microarray reference dataset \[[@pone.0236405.ref023]\]. Of these, sequences comprising the entire 5'UTR and 150 nt upstream of the transcription start site (TSS) were extracted and returned to MEME for motif prediction. The resulting motif was then re-submitted to FIMO to screen for Fur boxes across the entire *B*. *cenocepacia* J2315 genome.

*brrF* homologs were screened for using BLASTn \[[@pone.0236405.ref024]\], with search parameters adjusted to short sequences with low similarity: word size 7, match/mismatch scores -1/1, gap costs 0/2 and expect threshold 0.001.

Global alignments of *brrF* homologs were generated with LocARNA \[[@pone.0236405.ref025]\], using default parameters (see [S1 Fig](#pone.0236405.s001){ref-type="supplementary-material"} for strains and sequences used). Secondary structures of BrrF and selected mRNAs were predicted with mfold \[[@pone.0236405.ref026]\] and visualised using StructureEditor \[[@pone.0236405.ref027]\].

BrrF target prediction was performed with CopraRNA \[[@pone.0236405.ref011]\], using default parameters and the *Burkholderia* strains from [S1 Fig](#pone.0236405.s001){ref-type="supplementary-material"} as input strains. This algorithm takes accessibility of interaction sites and conservation of putative targets into account. Sequences adjacent to start codon of annotated genes, from 200 nt upstream to 100 nt downstream of the first nucleotide, were considered for target prediction; most confirmed sRNA-mRNA interactions are located in those regions. Predicted interactions located upstream of a known TSS \[[@pone.0236405.ref008]\] were removed from the results list. Functional enrichment analysis of predicted targets was performed with the DAVID tool \[[@pone.0236405.ref028]\], which is incorporated in CopraRNA.

Results and discussion {#sec011}
======================

Sequence, conservation, genome context and regulation of BrrF {#sec012}
-------------------------------------------------------------

BrrF is located within the 3' end of BCAL2297, a small protein designated HemP for its involvement in heme iron uptake in *Burkholderia multivorans* ([Fig 1A](#pone.0236405.g001){ref-type="fig"}, \[[@pone.0236405.ref029]\]). BrrF appeared to be cleaved from the *hemP* mRNA, as indicated by the strong depletion of the BrrF transcript by treatment with a 5'-monophosphate-dependent exonuclease (TEX, \[[@pone.0236405.ref008]\]). Its size was determined as 126 nt by dRNA-Seq (position 2548559 to 2548684 on replicon 1), confirmed by Northern blotting \[[@pone.0236405.ref009]\]. BrrF does not extend into the computationally predicted rho-independent terminator (position 2548709 to 2548732) downstream of *hemP*, instead it terminates a at succession of U-residues without a preceding stem loop. The same genome context was identified for the BrrF homolog BTH_s39 in *Burkholderia thailandensis*, which was identified using tiling microarrays \[[@pone.0236405.ref030]\]. BTH_s39 is also located downstream of *hemP* and does not extend into its computationally predicted downstream rho-independent terminator. The size of BTH_s39 was determined by rapid amplification of cDNA ends and confirmed by Northern blotting, and is, with 130 nt, a close match to BrrF.

![Genome context and expression of *brrF*.\
**A)** Coverage from differential RNA-Sequencing of a *B*. *cenocepacia* J2315 biofilm \[[@pone.0236405.ref008]\]. RNA samples were divided and one sub-sample treated with a 5'-monophosphate-dependent exonuclease (TEX), which selectively degrades processed transcripts. Reads starting at position 2548277 are enriched in the TEX-treated subsample, representing a transcription start site (TSS). Reads starting at position 2548559 are depleted by TEX-treatment, suggesting cleaving of the mRNA at this site. The *hemP* TSS (black arrow) is preceded by a 19 nt long Fur binding site (green box) and putative OxyR binding sites (blue boxes). Underlined: -10 and -35 box. Grey boxes: predicted rho-independent terminators. Pink box: *hemP* start codon. The diamond-ended lines below *brrF* depict the sizes of plasmid inserts for complementation (orange) and of the qPCR amplicon (black). **B)** Conserved genome context of *brrF*. On the upstream side, *brrF* is always flanked by *hemP* (light blue), downstream either by the *ftr* cluster for iron transport (dark blue) or a heme binding protein (light green). Identical colour denotes homologous proteins.](pone.0236405.g001){#pone.0236405.g001}

Although the 5'end of BrrF (GUAUU) bears similarities with typical RNase E consensus recognition sites in *E*. *coli* (RN↓WUU \[[@pone.0236405.ref031]\]), it is not cut at the central AUU as is typical for RNase E in that bacterium, but upstream of the first guanosine residue (CGA↓GUAUU, [Fig 2A](#pone.0236405.g002){ref-type="fig"}). The RNase recognition sequences in *B*. *cenocepacia* have not been systematically investigated, but the putative cutting sites of two other processed *B*. *cenocepacia* sRNAs (ncS35 CGA↓UUC \[[@pone.0236405.ref016]\], ncS27 CGA↓AUG \[[@pone.0236405.ref032]\]) are somewhat similar to the putative BrrF cutting site. This indicates that RNase recognition sites in *B*. *cenocepacia* differ from those in *E*. *coli*, and that one possible consensus recognition site might be CGA↓NUN.

![Interactions of BrrF with mRNA targets.\
**A)** Computationally predicted secondary structure of BrrF. Red bases are conserved across \>95% of screened strains of genera *Burkholderia*, *Paraburkholderia*, *Pandoraea* and *Cupriavidus*. Yellow bases indicate the successive guanosine residues that were replaced by cytosine for overexpression experiments. Bases involved in predicted interactions with selected mRNA targets are shaded in colour. The black arrow indicates the putative cutting site. **B)** Computationally predicted interactions with mRNAs of *acnA*, *fumA*, *sdhC*, *katB*, *sodB* and *sdhA*. The numbers indicate nucleotide positions relative to the start of the coding sequence for the respective mRNA (upper sequence 5' to 3' from left to right) or the nucleotide position in BrrF (lower sequence, 5' to 3' from right to left). Nucleotide positions altered in overexpression experiments are in red.](pone.0236405.g002){#pone.0236405.g002}

*brrF* is conserved over the full length in the genera *Burkholderia* (100% coverage, 90--100% identity), *Paraburkholderia* (100% coverage, 81--89% identity) and in *Pandoraea* (100% coverage, 70--74% identity, [S1 Fig](#pone.0236405.s001){ref-type="supplementary-material"}). In particular the 5' end (nucleotides 4--45) shows a high degree of conservation. In the genus *Cupriavidus*, only nucleotides 4 to 76 are present (57% coverage, 75--80% identity). No similar sequences were found outside the order *Burkholderiales*. The genome context is also conserved, *brrF* is always located downstream of a *hemP* homolog. Located downstream of *brrF* is either the ferrous iron uptake operon FtrABCD \[[@pone.0236405.ref033]\] or a heme-binding protein ([Fig 1B](#pone.0236405.g001){ref-type="fig"}). The computationally predicted secondary structure of BrrF shows extensive internal base pairing, with two conserved hairpins at the 5' end ([Fig 2A](#pone.0236405.g002){ref-type="fig"}).

BrrF was previously found to be more than 50-fold up-regulated under iron-depleted conditions, whereas other tested growth conditions such as biofilm growth, oxidative stress, stationary phase and starvation did not induce BrrF expression \[[@pone.0236405.ref009]\]. *hemP* was upregulated by iron depletion to approximately the same fold change as *brrF*. HemP in *B*. *multivorans* is Fur regulated \[[@pone.0236405.ref021], [@pone.0236405.ref029]\]; therefore the Fur box consensus sequence for *B*. *cenocepacia* was determined ([S2 Fig](#pone.0236405.s002){ref-type="supplementary-material"}) and the whole genome screened for motif occurrences. Fur boxes were identified directly upstream of the TSS for *hemP* ([Fig 1A](#pone.0236405.g001){ref-type="fig"}), and upstream of known iron transport-related genes such as *orbS* and *fecI*. The sequence upstream of the *hemP* gene start in *B*. *cenocepacia* is identical to that upstream of *hemP* in *B*. *multivorans* for the first 77 nt, which includes the Fur box. This *B*. *multivorans* sequence was bound by *B*. *multivorans* Fur protein in an electrophoresis mobility shift assay \[[@pone.0236405.ref021]\], the respective sequence in *B*. *cenocepacia* is therefore likely also bound by Fur.

*brrF* itself did not have a Fur box directly upstream of its 5' end. Expression of BrrF is therefore probably under control of the Fur regulator via co-expression with *hemP*. In contrast to that, the Fur-regulated sRNAs RyhB in *E*. *coli* and PrrFs in *P*. *aeruginosa* are directly preceded by a Fur binding site.

*hemP* is possibly also under the regulation of OxyR. A putative OxyR box was found upstream of *hemP* ([Fig 1A](#pone.0236405.g001){ref-type="fig"}), and *hemP* was upregulated 10-fold in H~2~O~2~-treated biofilms of *B*. *cenocepacia* J2315 \[[@pone.0236405.ref034]\] while in exponentially growing planktonic cells exposed to H~2~O~2~, neither *hemP* nor *brrF* change expression \[[@pone.0236405.ref009], [@pone.0236405.ref023]\]. However, in these studies biofilms were treated with 3% H~2~O~2~ for 30 min, whereas planktonic cultures were treated with 0.05 or 0.15% H~2~O~2~ for a shorter time period, which might account for the observed differences in *hemP* regulation under oxidative stress.

Computationally predicted targets of BrrF {#sec013}
-----------------------------------------

Target prediction resulted in 206 genes with sequence complementarity to BrrF (p-value ≤ 0.01, [S3 Table](#pone.0236405.s007){ref-type="supplementary-material"}). The categories with the largest number of genes with known function were amino acid transport and metabolism (12.6%) and energy production and conversion (10.0%). Most predicted interactions involved the 5' end of BrrF ([S3 Table](#pone.0236405.s007){ref-type="supplementary-material"}, [S3 Fig](#pone.0236405.s003){ref-type="supplementary-material"}), notable exceptions were targets *sdhC* and *sdhA* ([Fig 2B](#pone.0236405.g002){ref-type="fig"}). The predicted interaction regions in putative target mRNAs are located across the entire input region from 200 nt upstream to 100 nt downstream of the gene start ([S3 Fig](#pone.0236405.s003){ref-type="supplementary-material"}). Only a small proportion (17%) of the predicted mRNA interactions include the first 10 nt upstream of the gene start and the Shine-Dalgarno sequence, whereas most interactions were predicted for further upstream in the 5'UTR (38%) or within the coding sequence (45%, [S3 Table](#pone.0236405.s007){ref-type="supplementary-material"}). Secondary structure analysis of putative target mRNAs before and after virtual cleavage at the predicted interaction site did not indicate an occlusion of Shine-Dalgarno sequences by mRNA intramolecular structures. This indicates that binding of BrrF does not alter the rate of translation initiation, but that BrrF mainly acts by interfering with mRNA target degradation rate.

Functional enrichment analysis of predicted targets pointed to a relative over-representation of genes involved in aerobic respiration, iron- or heme-binding, and in the TCA cycle \[[@pone.0236405.ref009]\]. Furthermore, several genes involved in iron-sulfur cluster formation and in ROS detoxification, such as those encoding catalases and SOD, were predicted as targets ([Table 1](#pone.0236405.t001){ref-type="table"}). These genes or functional categories are also targeted by RyhB and/or PrrF (see [Table 1](#pone.0236405.t001){ref-type="table"} for references).

10.1371/journal.pone.0236405.t001

###### Regulation of computationally predicted BrrF target genes in response to iron depletion.

![](pone.0236405.t001){#pone.0236405.t001g}

  Predicted target                Gene     Annotation                                                                                   Log2 fold change WT low Fe\*   Log2 fold change Δ*brrF* low Fe\*   Ref.\*\*
  ------------------------------- -------- -------------------------------------------------------------------------------------------- ------------------------------ ----------------------------------- ----------------------------------------------------------------------------
  TCA and methylcitrate cycle                                                                                                                                                                              
  BCAM0967                        *sdhC*   Heme-binding succinate dehydrogenase cytochrome b556 subunit                                 -1.28                          n.s.                                \[[@pone.0236405.ref005], [@pone.0236405.ref010]\]
  BCAM0969                        *sdhA*   Succinate dehydrogenase flavoprotein subunit                                                 -2.25                          n.s.                                \[[@pone.0236405.ref005], [@pone.0236405.ref010]\]
  BCAM0961                        *acnA*   \[Fe-S\]-dependent aconitate hydratase A                                                     -4.22                          n.s.                                \[[@pone.0236405.ref010], [@pone.0236405.ref035]\]
  BCAL2287                        *fumA*   \[Fe-S\]-dependent class I fumarate hydratase                                                -5.38                          1.10                                \[[@pone.0236405.ref010], [@pone.0236405.ref035]\]
  BCAL2908                        *fumC*   Class II fumarate hydratase, iron-free                                                       1.76                           0.42                                \[[@pone.0236405.ref036]\]
  BCAM2701                        *acnM*   \[Fe-S\]-dependent 2-methylisocitrate dehydratase                                            -2.00                          n.s.                                
  Defense against ROS                                                                                                                                                                                      
  BCAL2757                        *sodB*   Fe^2+^-containing SOD                                                                        -2.33                          0.75                                \[[@pone.0236405.ref005], [@pone.0236405.ref010]\]
  BCAL3299                        *katB*   Bifunctional heme-containing catalase/peroxidase, homologous to *katG* in *E*. *coli*        -1.72                          0.98                                \[[@pone.0236405.ref036], [@pone.0236405.ref037]\]
  BCAM0931                                 Monofunctional heme-containing catalase clade 1, homologous to *katA* in *P*. *aeruginosa*   -0.83                          -0.18                               \[[@pone.0236405.ref005]\]
  Aerobic respiration                                                                                                                                                                                      
  BCAL2336                        *nuoI*   \[Fe-S\]-dependent NADH dehydrogenase subunit I                                              n.d.                           n.d.                                \[[@pone.0236405.ref010], [@pone.0236405.ref037]\]
  BCAL2343                        *nuoB*   \[Fe-S\]-dependent NADH dehydrogenase subunit B                                              -1.20                          n.s.                                \[[@pone.0236405.ref010]\]
  BCAL0785                        *cydA*   Heme-binding cytochrome bd-I ubiquinol oxidase subunit 1                                     n.d.                           n.d.                                \[[@pone.0236405.ref010]\]
  BCAL2143                        *cyoB*   Heme-binding cytochrome bo ubiquinol oxidase subunit 1                                       n.s.                           n.s.                                \[[@pone.0236405.ref038]\]
  Iron-sulfur cluster formation                                                                                                                                                                            
  BCAL2196                        *iscA*   \[Fe-S\] assembly accessory protein                                                          n.d.                           n.d.                                \[[@pone.0236405.ref010], [@pone.0236405.ref037]\]
  BCAL2198                        *iscS*   Cysteine desulfurase                                                                         n.d.                           n.d.                                \[[@pone.0236405.ref010], [@pone.0236405.ref035], [@pone.0236405.ref036]\]
  Other                                                                                                                                                                                                    
  BCAL3367                        *edd*    \[Fe-S\]-dependent phosphogluconate dehydratase                                              -3.60                          -1.54                               

\*Log2-fold change after addition of 200 μM dipyridyl to a culture at mid-log phase, harvest after 30 min of further incubation, compared to untreated culture. The threshold for reporting statistically significant fold changes was p ≤ 0.05, n. s. denotes "not significant". The actual p-values from SPSS ANOVA analysis are presented in [S4 Table](#pone.0236405.s008){ref-type="supplementary-material"}. \[Fe-S\]: Iron-sulfur cluster, n.d. not determined. Ref.\*\*: references for regulation by RyhB and/or PrrF.

The target prediction results and the similarity of BrrF to other Fur-regulated sRNAs suggests that BrrF is a regulator of the TCA cycle and of the oxidative stress response under conditions of iron depletion, most likely by down-regulating the putative target genes. Down-regulating genes encoding SdhC, SodB and other iron-containing proteins saves iron and facilitates iron homeostasis. Iron limitation and a decreased activity of TCA cycle enzymes leads to a decrease in ROS production, reducing the need for ROS detoxification. BrrF-dependent regulation could therefore also save energy and contribute to overall homeostasis in the bacterial cell.

A link between iron availability and expression of ROS detoxifying genes has previously been demonstrated in *B*. *multivorans*. A *B*. *multivorans* Fur mutant showed increased sensitivity to oxidative stress, reduced *sodB* expression and reduced SOD and catalase activities \[[@pone.0236405.ref021]\]; and also growth attenuation on many carbon compounds. These phenotypes could be complemented by deleting *hemP* together with the BrrF sequence from the *B*. *multivorans* genome \[[@pone.0236405.ref029]\].

BrrF affects growth in *B*. *cenocepacia* J2315 {#sec014}
-----------------------------------------------

The deletion mutant Δ*brrF* had no growth defect compared to wild type (WT) in iron-replete media, neither in a rich medium nor during growth on single carbon sources in a mineral medium ([Fig 3A](#pone.0236405.g003){ref-type="fig"} and [S4 Fig](#pone.0236405.s004){ref-type="supplementary-material"}). Δ*brrF* was also not impaired in heme utilisation, indicating that expression of HemP is not affected by *brrF* deletion ([S4 Fig](#pone.0236405.s004){ref-type="supplementary-material"}). Under iron limitation, Δ*brrF* grew marginally faster than WT. This is in contrast to observations with a PrrF double deletion mutant in *P*. *aeruginosa*, which showed a growth defect compared to wild type under iron depletion \[[@pone.0236405.ref039]\]. *B*. *cenocepacia* J2315 is a slow growing small colony variant and possibly less affected by iron starvation. That Δ*brrF* is less growth attenuated than WT under iron limitation suggests that key metabolic genes are down-regulated by BrrF.

![Growth of *B*. *cenocepacia* J2313 strains during iron depletion and BrrF overexpression.\
**A)** Left: Wild type and Δ*brrF* were attenuated by iron depletion (addition of 200 μM dipyridyl), Δ*brrF* to a lesser extent than wild type. Right: Overexpressing the native form of BrrF (BrrF-d1 and -d2) under iron-replete conditions attenuated growth. Introducing mutations in the 5' end of BrrF (BrrF-d3) abolished the growth attenuating effect of BrrF overexpression. **B)** On substrates such as succinate and gluconate, overexpressing BrrF attenuated growth. On propionate no attenuation was observed. **C)** Under iron depletion (FeSO~4~ omitted from mineral medium), Δ*brrF* grew to a higher O.D. than WT with succinate and gluconate as substrate, while the opposite was true on propionate. Growth was monitored in LB broth in flasks by a Cell Growth Quantifier (A) or in mineral medium in microtiter plates (B, C), the carbon source concentration was 20 mM. Significant differences in growth rate of the wild type or wild type vector control culture and the respective test condition are indicated by asterisks (\* = p \< 0.05, \*\* = p \< 0.01).](pone.0236405.g003){#pone.0236405.g003}

Overexpressing BrrF from a vector (WT-pBrrF-d1 and WT-pBrrF-d2) attenuated growth ([Fig 3B](#pone.0236405.g003){ref-type="fig"}). Overexpressing a derivative of BrrF with point mutations near its 5'end abolished this effect, showing that the growth attenuation depended on the BrrF region which produced the most computationally predicted interactions ([Fig 3A](#pone.0236405.g003){ref-type="fig"}).

To test whether growth attenuation by BrrF overexpression was substrate dependent, growth curves were obtained in iron-replete mineral medium supplemented with single carbon compounds. Overexpressing BrrF attenuated growth on nearly all carbon sources tested, including on TCA cycle intermediates such as succinate, citrate, malate and fumarate, on carbohydrates such as glycerol, glucose and gluconate, and on amino acids. Growth of Δ*brrF* under iron depletion was tested on five compounds, and it grew faster than WT on four of them ([Fig 3C](#pone.0236405.g003){ref-type="fig"} and [S4 Fig](#pone.0236405.s004){ref-type="supplementary-material"}). This is consistent with a BrrF-dependent downregulation of the TCA cycle, since nearly all growth substrates are either directly or indirectly metabolised through the TCA cycle. The notable exception was propionate, growth on which was not affected by BrrF overexpression under iron-replete conditions, and on which Δ*brrF* grew marginally slower than WT under iron depletion. Propionate is metabolised via the methylcitrate cycle in *B*. *cenocepacia* \[[@pone.0236405.ref040]\], and the lack of growth attenuation on this substrate suggests that this pathway is less affected by BrrF-dependent down-regulation.

BrrF regulates the TCA cycle {#sec015}
----------------------------

To test the hypothesis that BrrF induction causes down-regulation of the expression of genes encoding TCA cycle enzymes, all predicted target genes involved in the TCA cycle, and some additional TCA cycle genes which were not predicted targets, were assessed for BrrF-dependent gene expression changes. All samples were collected 30 min after adding rhamnose and/or dipyridyl to cultures initially grown without inducer.

In the WT strain, all TCA genes with complementarity to BrrF were differentially regulated in response to iron depletion. Most of the genes were downregulated, with *acnA* and *fumA* most affected ([Table 1](#pone.0236405.t001){ref-type="table"}, [Fig 4](#pone.0236405.g004){ref-type="fig"}). *fumC*, encoding an iron-free fumarate hydratase with an analogous function to \[4Fe-4S\]-dependent FumA, was upregulated under iron depletion. In Δ*brrF*, this regulation was attenuated or abolished ([Table 1](#pone.0236405.t001){ref-type="table"}, Figs [4](#pone.0236405.g004){ref-type="fig"} and [5](#pone.0236405.g005){ref-type="fig"}). Of the TCA cycle enzymes not predicted as targets, only *gltA* was downregulated significantly in WT under iron depletion. *gltA* is located downstream of and in the same operon as *sdhABCD* \[[@pone.0236405.ref041]\] and the reduced expression of *gltA* under iron depletion is therefore likely a downstream effect of *sdhC* and *sdhA* downregulation. Of the putative target genes tested, only *fumC* is upregulated under iron depletion, and in a BrrF-dependent manner. In *E*. *coli fumC* is upregulated under iron depletion via iron-dependent activation by the SoxR protein, probably as an iron-saving measure \[[@pone.0236405.ref042]\]. In *P*. *aeruginosa*, expression of *fumC* is Fur-regulated \[[@pone.0236405.ref043]\], whereas no Fur box is associated with *fumC* in *B*. *cenocepacia* J2315. The upregulation of *fumC* expression observed in the present study can therefore be a result of BrrF interacting with *fumC* mRNA.

![BrrF-dependent regulation of genes of the tricarboxylic acid and methylcitrate cycle in response to iron depletion.\
Iron depletion was invoked by adding dipyridyl to a final concentration of 200 μM to a culture in mid-log phase (LB broth, incubated on a shaker). Cells were then harvested for RNA extraction after 30 min further incubation. This pulse-expression set-up was chosen to minimize secondary effects of iron depletion on gene expression. Predicted targets are underlined. In colored boxes: log2-fold gene expression changes upon iron depletion in WT (left) and Δ*brrF* (right). Grey boxes denote no significant changes in expression (i.e. p \> 0.05). Bottom right: Color scale for log2-fold changes.](pone.0236405.g004){#pone.0236405.g004}

![BrrF-dependent expression of computationally predicted targets under low iron condition.\
Cells were harvested for RNA extraction after "pulse-expression" of 30 min in a mid-log culture. Downregulation of gene expression could be complemented in Δ*brrF* by overexpressing BrrF *in trans*. Complementation was dependent on the 5'end of BrrF for most genes except for *sdhA* and *sdhC*. Light grey: Expression compared to iron-replete condition. Dark grey: Expression compared to Δ*brrF*-vector control. pBrrF-d1 and pBrrF-d2: plasmids overexpressing native BrrF with or without processing. pBrrF-d3: derivative of pBrrF-d2 with point mutations near the BrrF 5'end. Asterisks: Significant difference to the respective control, with p ≤ 0.05.](pone.0236405.g005){#pone.0236405.g005}

sRNAs capable of both repressing and activating gene expression have been described \[[@pone.0236405.ref044]\]. The most common mechanisms for activation are reduction of secondary structure in the region of the Shine-Dalgarno sequence, and occluding RNase sensitive sites \[[@pone.0236405.ref045]\]. BrrF is predicted to interact with fumC mRNA in its 5'UTR, 65 to 75 nt upstream of the gene start. Secondary structure analysis of the fumC 5'UTR revealed a rho-independent terminator-like hairpin structure at position 32 to 51 from gene start, suggesting transcription termination as a possible mechanism of FumC expression regulation. However, the putative interaction site does not overlap the hairpin structure, and cleaving the 5'UTR at the interaction site does not change the structure of the predicted hairpin. The mechanism of transcription activation by BrrF is therefore not apparent from secondary structure analysis.

Overexpressing BrrF in Δ*brrF* under iron-depletion complemented the downregulation of the tested genes ([S4 Table](#pone.0236405.s008){ref-type="supplementary-material"}, [Fig 5](#pone.0236405.g005){ref-type="fig"}), whereas overexpressing the BrrF derivative with mutations at its 5' end (pBrrF-d3) abolished or reduced that effect, with the notable exception of *sdhC* and *sdhA*. The BrrF region predicted to be important for the interaction with these two genes is further away from the 5' end and is not altered in pBrrF-d3 ([Fig 2A and 2B](#pone.0236405.g002){ref-type="fig"}). The abundance of the three BrrF derivatives over-expressed *in trans* was similar ([S5 Table](#pone.0236405.s009){ref-type="supplementary-material"}).

Under iron-replete conditions, overexpressing BrrF in the wild type strain significantly repressed *acnA* and *fumA*, and induced *fumC* ([S4 Table](#pone.0236405.s008){ref-type="supplementary-material"}). In line with this, aconitase activity was also reduced by BrrF overexpression ([Fig 6](#pone.0236405.g006){ref-type="fig"}). This suggests that growth attenuation during BrrF overexpression under iron-replete conditions ([Fig 3B](#pone.0236405.g003){ref-type="fig"}) is mainly due to repression of *acnA*. Expression of *sdhA* and *sdhC* is not affected in this condition, and metabolism of propionate via the methylcitrate cycle completely bypasses AcnA ([Fig 4](#pone.0236405.g004){ref-type="fig"}). Fumarate dehydratase activity might overall not be affected by BrrF overexpression, because FumC can replace FumA.

![BrrF-dependent reduction in aconitase activity.\
Cultures were grown under iron-replete conditions in LB broth to mid-log phase and rhamnose was added one hour before harvest and protein extraction. Cell-free protein extracts in a 20 mM citrate buffer were supplemented with 40 mM DL-isocitrate and increase in absorbance was measured at 240 nm in a spectrophotometer. Asterisks: Significant difference to the respective control, with p ≤ 0.05. VC: vector control.](pone.0236405.g006){#pone.0236405.g006}

BrrF regulates the response to oxidative stress {#sec016}
-----------------------------------------------

Predicted targets genes *sodB* and *katB* were downregulated significantly in WT under low iron condition ([Table 1](#pone.0236405.t001){ref-type="table"}, [Fig 5](#pone.0236405.g005){ref-type="fig"}). SOD activity was significantly reduced in WT cultures under iron limitation, while SOD activity in Δ*brrF* remained unchanged compared to iron-replete condition ([Fig 7A](#pone.0236405.g007){ref-type="fig"}). Reduced SOD activity could be complemented by overexpressing the native BrrF in Δ*brrF in trans*, while overexpressing the mutated BrrF derivative did not complement the phenotype. In a H~2~O~2~ sensitivity assay, overexpression of BrrF in Δ*brrF* lead to a significant increase of size of inhibition zone ([Fig 7B](#pone.0236405.g007){ref-type="fig"}).

![BrrF-dependent regulation of the oxidative stress response.\
**A)** SOD activity was determined in a cell-free protein extract from planktonic mid-log phase cells, indirectly via superoxide utilization of a xanthine oxidase. Results are presented as percent compared to control condition. **B)** Sensitivity to H~2~O~2~ was determined on low-nutrient agar plates, via formation of a growth inhibition zone around a filter disk containing 1% H~2~O~2~. Plates were pre-incubated for one hour to induce gene expression changes before applying the filter disks. Light grey bars: Response to iron depletion in wild type (WT) and Δ*brrF*. Dark grey bars: Overexpression of native BrrF with or without processing (pBrrF-d1 and pBrrF-d2) or of a derivative with point mutations near the BrrF 5'end (pBrrF-d3). Asterisks: Significant difference to the respective control, with p ≤ 0.05. VC: vector control.](pone.0236405.g007){#pone.0236405.g007}

*B*. *cenocepacia* J2315 has two SODs, the cytoplasmic iron-containing SodB (BCAL2757) and the periplasmic Cu-Zn-containing SodC (BCAL2643) \[[@pone.0236405.ref041], [@pone.0236405.ref046]\]. However, only *sodB* is predicted as target for BrrF, and only *sodB* changed expression significantly ([S4 Table](#pone.0236405.s008){ref-type="supplementary-material"}). The observed SOD activity changes are therefore probably caused by *sodB* expression changes.

The *B*. *cenocepacia* J2315 genome encodes four catalases \[[@pone.0236405.ref041]\], the bifunctional, heme containing catalase/peroxidases KatA (BCAM2107, \[[@pone.0236405.ref020]\]) and KatB (BCAL3299, \[[@pone.0236405.ref020], [@pone.0236405.ref047]\]), an additional monofunctional heme-containing catalase (BCAM0931) and a manganese-containing catalase (BCAS0635). *katB* and BCAM0931 are predicted as targets for BrrF. *katA* did not change expression upon iron depletion ([S4 Table](#pone.0236405.s008){ref-type="supplementary-material"}) and BCAS0635 is not expressed under iron-replete conditions \[[@pone.0236405.ref016]\]. Taken together, this suggest the increased sensitivity to H~2~O~2~ is linked to downregulation of *katB*, which is the major determinant for catalase activity in *B*. *cenocepacia* \[[@pone.0236405.ref020]\]. Concomitantly, baseline expression of *katB* is relatively high compared to *katA*, with a 2-fold reduction in the media containing rhamnose and trimethoprim which were used for overexpression experiments ([S5 Table](#pone.0236405.s009){ref-type="supplementary-material"}). This lower expression of *katB* could be the reason for the larger effect of BrrF overexpression on H~2~O~2~ sensitivity compared to induction of BrrF by low iron ([Fig 7](#pone.0236405.g007){ref-type="fig"}), as this would increase the excess of BrrF relative to its target *katB*.

BrrF-dependent regulation of other predicted targets {#sec017}
----------------------------------------------------

While computational target prediction often results in a large number of false positive predicted targets \[[@pone.0236405.ref011]\], BrrF likely regulates additional genes besides the ones mentioned above.

Other predicted targets of BrrF are also involved in metabolism. The nuo respiratory complex is known to be repressed by RyhB in *E*. *coli* under iron depletion \[[@pone.0236405.ref048]\], while cytochrome bo oxidase genes *cyoABC* are regulated by RyhB in *Salmonella typhimurium* in response to nitrosative stress \[[@pone.0236405.ref038]\]. *cyoB* and *nuoB* were tested for BrrF-dependent gene expression changes; *nuoB* was downregulated in WT under iron depletion ([Table 1](#pone.0236405.t001){ref-type="table"}), while *cyoB* did not change expression.

The *edd* gene (BCAL3367; encoding a \[Fe-S\]-cluster containing phosphogluconate dehydratase) was downregulated in response to iron depletion in a BrrF-dependent manner ([Table 1](#pone.0236405.t001){ref-type="table"}, [S4 Table](#pone.0236405.s008){ref-type="supplementary-material"}). *edd* is the first gene of the Entner-Doudoroff pathway for carbohydrate degradation, particularly important in *B*. *cenocepacia* because *Burkholderia* spp. lack a complete glycolysis pathway. Moreover, *edd* is upregulated by H~2~O~2~ stress \[[@pone.0236405.ref023]\], and has been implicated in the oxidative stress response of *Pseudomonas putida* \[[@pone.0236405.ref049]\]. In *P*. *putida*, an organism also lacking a complete glycolysis pathway, phosphogluconate dehydratase is necessary for generating NADPH in order to combat oxidative stress. Therefore, downregulating phosphogluconate dehydratase is possibly not only saving iron, but also contributing to overall NADPH balance in the cell.

Conclusion {#sec018}
==========

Our results demonstrate that sRNA BrrF is involved in downregulating TCA and oxidative stress response in *B*. *cenocepacia* J2315. This sRNA can be added to the growing list of sRNA involved in regulating metabolism, growth and stress responses in the versatile opportunistic pathogen *B*. *cenocepacia* \[[@pone.0236405.ref016], [@pone.0236405.ref032]\].

The exact molecular mechanisms of BrrF regulation remain to be resolved. RyhB regulates target genes mainly by binding to its cognate sequence and subsequently increasing the rate of mRNA degradation. This process is Hfq- and RNase E-dependent \[[@pone.0236405.ref050]\]. It seems likely that BrrF also acts this way, as its sequence is complementary to homologs of confirmed RyhB targets, and most interactions do not include the Shine-Dalgarno sequence of target mRNAs. However, indirect regulation by BrrF via a different yet unknown mechanism cannot be ruled out.

Supporting information {#sec019}
======================

###### Conservation and secondary structure of BrrF homologues.

The full length of BrrF is very conserved throughout *Burkholderia* (first 8 lines), *Paraburkholderia* (lines 9--16) and *Pandoraea* sp. (lines 17--21). In *Cupriavidus* sp. (lines 22--26) only the first 45 nt of BrrF are present. Underlined are bases conserved in all sequences. Consensus secondary structures were computed using the sequences of the alignment. Red: fully conserved compatible base pairs. Alignment and consensus structures were computed using LocARNA \[[@pone.0236405.ref025]\].

(TIF)

###### 

Click here for additional data file.

###### Fur box consensus sequence for *B*. *cenocepacia* J2315.

The canonical 19 bp palindromic Fur binding site is indicated by a bracket.

(TIF)

###### 

Click here for additional data file.

###### Density plots of predicted interaction regions.

mRNA regions are depicted in the upper panel and sRNAs regions in the lower panel. The graphs represent all predictions with P\< 0.01. x-axis depicts the nucleotide position, position 1 in mRNA is the first nucleotide of the coding sequence. The y-axis depicts the relative frequency of a nucleotide position being part of the predicted sRNA--target interactions.

(TIF)

###### 

Click here for additional data file.

###### Growth of *B*. *cenocepacia* J2313 strains during iron depletion and BrrF overexpression.

Growth was monitored in microtiter plates. y-axis: Optical density (590 nm). x-axis: Time (hours).

(TIF)

###### 

Click here for additional data file.

###### Strains and plasmids used in this study.

(PDF)

###### 

Click here for additional data file.

###### Primers used in this study.

(PDF)

###### 

Click here for additional data file.

###### Computationally predicted targets of BrrF.

(XLSX)

###### 

Click here for additional data file.

###### All log2-fold changes in gene expression determined by qPCR.

(PDF)

###### 

Click here for additional data file.

###### All qPCR raw Cq values.

(XLSX)

###### 

Click here for additional data file.
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\[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link \"View Attachments\". If this link does not appear, there are no attachment files to be viewed.\]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <https://pacev2.apexcovantage.com/>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at <figures@plos.org>. Please note that Supporting Information files do not need this step.
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Author response to Decision Letter 0

9 Apr 2020

Manuscript " Low iron-induced small RNA BrrF regulates central metabolism and oxidative stress responses in Burkholderia cenocepacia" by Sass and Coenye

Response to reviewers' questions.

Reviewer 1:

-Line 341-342: BfrB in P. aeruginosa is not regulated by PrrF (see Figure 5 in Wilderman, et al, PNAS 2004). In E. coli, RyhB was suggested to regulate FtnA, not BfrB, but latter studies showed that iron induction of FtnA is similarly independent of RyhB (Nandal, et al, Mol Micro 2010).

Answer:

The reviewer is correct, this was an oversight on our side and we deleted the sentence from the discussion.

-The conclusion section should be expanded to discuss the following points:

1\. Figure 3. It seems counter that loss of a gene that is so highly conserved would result in a growth enhancement, especially when the loss of ryhB, PrrF, and other low-iron induced sRNAs results in a growth defect in low iron condition due to loss of iron sparing. This should at the very least be discussed in the concluding section.

Answer:

The B. cenocepacia strain used in this study, J2315, is a slow growing small colony variant. Strain J2315 permanently displays a growth deficiency compared to other B. cenocepacia laboratory strains such as K56-2 and H111. It is therefore probably less affected by iron starvation and can maintain growth for longer under those conditions compared to "normally" growing bacteria. Absence of downregulation of key metabolic genes, as in �brrF, can then increase growth, and not be detrimental to the survival of the bacteria.

We have added this rationale to the manuscript main text (lines 370-375: "This is in contrast to observations with a PrrF double deletion mutant in P. aeruginosa, which showed a growth defect compared to wild type under iron depletion \[39\]. B. cenocepacia J2315 is a slow growing small colony variant and possibly less affected by iron starvation. That �brrF is less growth attenuated than WT under iron limitation suggests that key metabolic genes are down-regulated by BrrF.").

2\. The authors state that many of the complementarities with BrrF targets do not overlap the SD or start site, which is contrast to other negatively regulated targets of trans-acting sRNAs. Have the authors looked at the structures of any of the target mRNAs to determine how binding by BrrF may affect access to the SD and/or start site?

Answer:

We have performed secondary structure analysis for the genes listed in Table 1, including the 5'UTR to max. 200 nt upstream of the gene start and to 100 nt downstream of the gene start. The putative interaction region was not involved in occluding the SD or the gene start, and repeating the analysis after virtual cleavage of the mRNA at the predicted interaction site did not reveal occlusion of SD or gene start after cleavage. Computational secondary structure analysis was therefore not informative regarding mechanism of action of BrrF.

We have added the findings from secondary structure analysis to the manuscript text (lines 330-332: "Secondary structure analysis of putative target mRNAs before and after virtual cleavage at the predicted interaction site did not indicate an occlusion of Shine-Dalgarno sequences by mRNA intramolecular structures.").

3\. Related, I'm curious if any complementarity was identified in the fumC mRNA - this distinction from how fumC is regulated by iron in other species (directly by Fur versus via the sRNA), is very interesting.

Answer:

Activation of expression by a small RNA is less common than downregulation. The most common mechanisms for activation are reduction of secondary structure in the region of the SD sequence, and occluding RNase sensitive sites.

Secondary structure analysis of the 5'UTR of fumC mRNA showed that it contains a hairpin formation at position 32 to 51 upstream of the gene start, which could act as a rho-independent terminator. The SD or gene start are not occluded by secondary structure formation according to this analysis. The binding site of BrrF is predicted for position 65 to 75, not overlapping the putative terminator structure. We repeated the secondary structure analysis after removing the RNA sequence upstream of and including the interaction site, and the terminator structure still formed unchanged. It is therefore not apparent from structure analysis what the exact mechanism of activation is.

We added the special characteristics of the fumC 5'UTR to the manuscript text (lines 431-441: "sRNAs capable of both repressing and activating gene expression have been described \[44\]. The most common mechanisms for activation are reduction of secondary structure in the region of the SD sequence, and occluding RNase sensitive sites \[45\]. BrrF is predicted to interact with fumC mRNA in its 5'UTR, 65 to 75 nt upstream of the gene start. Secondary structure analysis of the fumC 5'UTR revealed a rho-independent terminator-like hairpin structure at position 32 to 51 from gene start, suggesting transcription termination as a possible mechanism of FumC expression regulation. However, the putative interaction site does not overlap the hairpin structure, and cleaving the 5'UTR at the interaction site does not change the structure of the predicted hairpin. The mechanism of transcription activation by BrrF is therefore not apparent from secondary structure analysis.").

Reviewer 2:

-In lines 27-28, the authors state that \"BrrF is a Fur-regulated small RNA,\" however, in lines 296-297, the authors state that \"BrrF is therefore probably under the control of the Fur regulator.\" There is not direct evidence that Fur regulates brrF (or hemP for that matter) in B. cenocepacia. The authors are relying solely on the presence of putative \"Fur boxes\" for this conclusion. While suggestion that brrF \"might\" be controlled by Fur is an acceptable proposition, there authors have not presented any direct evidence that brrF is actually Fur-regulated.

Answer:

In the particular B. cenocepacia strain used for this study, Fur is an essential gene (reference Wong et al., 2016, Candidate essential genes in Burkholderia cenocepacia J2315 identified by genome-wide TraDIS. Front. Microbiol. 7:1288. doi: 10.3389/fmicb.2016.01288). In other Burkholderia strains, Fur can be deleted, and it has been deleted in B. multivorans, also a member of the Burkholderia cepacia complex and relatively closely related to B. cenocepacia. The Fur-dependent expression of the HemP protein upstream of BrrF has been demonstrated for that bacterium (ref. 21). The sequences upstream of hemP are identical in B. cenocepacia J2315 and the B. multivorans strain used in that study, including the Fur box. The sequence upstream of hemP of B. multivorans has been used in a Fur titration assay in that study (ref. 21), showing that E. coli Fur protein can bind to this Fur box sequence. The same sequence was also bound by B. multivorans Fur in an EMSA experiment (ref. 21). It is therefore very likely that the hemP upstream sequence in B. cenocepacia is also bound by Fur.

We have added these observations to the manuscript text, lines 302-307 ("The sequence upstream of the hemP gene start in B. cenocepacia is identical to that upstream of hemP in B. multivorans for the first 77 nt, which includes the Fur box. This B. multivorans sequence was bound by B. multivorans Fur protein in an electrophoresis mobility shift assay \[21\], the respective sequence in B. cenocepacia is therefore most likely also bound by Fur.")

-Regarding the deletion and over-expression of brrF, there are several important data that are missing. The authors have relied on qPCR to demonstrate levels of BrrF in all of their strains (Fig. S5), but the authors should employ another method, such as northern blot analysis. For example, Fig. S5 shows that the Cq value for BrrF in the brrF deletion strain in unstressed conditions is approximately 31-32, and the Cq for BrrF in the same strain under low Fe conditions is approximately 25. How can there be such a substantial increase in the levels of BrrF in the brrF deletion strain in different conditions? This shows the unreliable nature of qPCR for analyzing sRNAs. Moreover, given this issue, much of the data in the manuscript are difficult to interpret.

Answer:

The reason to show the qPCR raw data was to point out that the levels of BrrF in overexpression experiments under low iron conditions are comparable to the levels of BrrF in wild type under low iron conditions. In the brrF deletion mutant, Cq values for BrrF are between 25 and 32, which is indeed relatively high, given that BrrF should not have been detected. However, our no-RT controls showed that primers for BrrF always give signals in this order of magnitude, as Cq values for BrrF in no-RT controls ranged from 32 to 27. In contrast, no-RT control Cq values for all other genes investigated were always larger than 34. It appears that, for reasons unknown we had measurable brrF signals that were larger than for all the other genes investigated. However, whatever the reason for this high background signals, we are convinced they have no influence on our conclusions. After all, the Cq values for BrrF in wild type under iron replete conditions are approx. 15, while those under conditions where BrrF is induced are approx. 10-11. This difference between Cq values of 10-15 on one hand, and Cq values of 25-32 on the other hand, is large enough. Generally, no-RT and no-template control Cq values should be \>5 cycles larger than sample Cq values, to contribute \<3% to the signal (Nolan et al., 2006, Quantification of mRNA using real-time RT-PCR. Nat. Meth. 1:1559, doi:10.1038/nprot.2006.236), and this is clearly the case for our data . Because of this we believe our qPCR data are reliable and we decided not to quantify BrrF expression in another way.

We have supplied all qPCR raw Cq values, including no-RT controls, as supplementary material, in Table S5, and have removed Figure S5, since it depicts data which is now available in Table S5.

-Also regard the deletion strain, are hemP levels altered by deletion of brrF? If so, it is very difficult to conclude that any phenotypes observed are related only to BrrF.

Answer:

hemP mRNA levels were shown in Figure S5 on the right hand side, they are not altered by brrF deletion. We have now supplied all qPCR raw data in Table S5.

We conducted additional growth curves to assess the functionality of HemP. HemP is necessary for heme uptake in B. multivorans (ref. 29); and our results showed that a brrF deletion mutant was not impaired in heme utilization (Figure S4). It is therefore reasonable to assume that HemP expression is not altered by brrF deletion, and that the observed phenotypes of �brrF are not related to hemP.

We have added the results of the additional growth tests to the main text (lines 368-369: "�brrF was also not impaired in heme utilisation, indicating that expression of HemP is not affected by brrF deletion (Fig. S4)."), and added representative growth curves, showing the effect of heme addition to the low iron medium, to Figure S4 in supplementary material.

-Figure 3 should be statistically analyzed. The authors state that strains are \"marginally\" different, but are these differences statistically significant?

Answer:

To perform the statistical analysis for all available data as consistently as possible, we analyzed the growth rates. Part of the growth curves in Figure 3 were obtained with a Cell Growth Quantifier, which runs with CGQuant software with automated growth rate calculation. The equation used by the CGQuant software to calculate time averaged growth rates was applied to the output of the microplate reader. The resulting growth rates were then statistical analyzed. The method section has been amended accordingly (lines 140-144: "Growth rates were determined using the equation µ \* h-1 = ln (xt2/xt1)/(t2-t1), where x denotes optical density or backscatter arbitrary units, and t1 and t2 refer to a point at the beginning or end of the analysed time interval, respectively \[17\]. The obtained values for µ of the biological replicates were then analysed either by One-way ANOVA or a two-tailed Student's t-test using SPSS (v. 25)."), as well as the legend to Figure 3 (lines 392-394: "Significant differences in growth rate of the wild type or wild type vector control culture and the respective test condition are indicated by asterisks (\* = p \< 0.05, \*\* = p \< 0.01)."). Statistically significant different growth rates are indicated in Figure 3.

-Lines 453-460 and Figure 7. These data are extremely difficult to understand. To begin with, the authors use confusing terminology: \"significant increase of inhibition.\" This appears to translate to increase sensitivity, but it is hard to know exactly.

Answer:

We have changed the wording of this sentence from "significant increase of inhibition" to "significant increase in size of inhibition zone" (line 493) to clarify.

-Regarding the data, WT vs. WT in low Fe shows no difference in sensitivity to oxidative stress, and there should be a \>50-fold increase in BrrF in the WT-low Fe condition compared to WT based on the authors previous work (Ref. 9). Additionally, the brrF deletion strain in both conditions has similar sensitivity levels to those of the WT and WT-low Fe. However, when you over-express versions of brrF in the brrF deletion strain, these strains exhibit increased sensitivity to oxidative stress. Is there a greater than 50-fold increase in BrrF in these strains? Can over-expression of these brrF genes in the WT strain similarly increase sensitivity to oxidative stress. The authors need to carefully evaluate the results from these experiments.

Answer:

The variations of the effect of BrrF induction on H2O2 sensitivity in WT under low iron (not significant) and in �brrF with BrrF expression complemented under low iron condition (significant) is probably not due to a difference in BrrF expression in these two strains as the reviewer suggested, but due to a reduction of katB expression under the condition of BrrF overexpression. katB is approx. 2-fold lower expressed in media containing rhamnose and trimethoprim, which are used for overexpression experiments. This increases the excess of BrrF in comparison to its target katB mRNA, and could cause an increase in katB down-regulation, which is also apparent in katB Cq values under this condition.

We have supplied all the qPCR raw data (Table S5), and added the above explanation to the manuscript text (lines 519-524: "Concomitantly, baseline expression of katB is relatively high compared to katA, with a 2-fold reduction in the media containing rhamnose and trimethoprim which were used for overexpression experiments (Table S5). This lower expression of katB could be the reason for the larger effect of BrrF overexpression on H2O2 sensitivity compared to induction of BrrF by low iron (Fig 7), as this would increase the excess of BrrF relative to its target katB.").
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13 May 2020

PONE-D-19-34895R1

Low iron-induced small RNA BrrF regulates central metabolism and oxidative stress responses in *Burkholderia cenocepacia*

PLOS ONE

Dear Dr. Sass,

Both reviewers have pointed out that apparently it has not been experimentally established that Fur regulates the iron responsive expression of *brrF* in *Burkholderia cenocepacia*. If  this is correct, then these reviewers are correct that this point needs to be clarified. Other than clarification of  this important point, both reviewers agree that the manuscript presents important findings. Consequently, I am going to ask that you submit a revised version of  the paper that directly addresses this issue and once this point is clarified, I will accept the manuscript.

We would appreciate receiving your revised manuscript by July 15, 2020. When you are ready to submit your revision, log on to <https://www.editorialmanager.com/pone/> and select the \'Submissions Needing Revision\' folder to locate your manuscript file.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter.

To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: <http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols>

Please include the following items when submitting your revised manuscript:

A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). This letter should be uploaded as separate file and labeled \'Response to Reviewers\'.A marked-up copy of your manuscript that highlights changes made to the original version. This file should be uploaded as separate file and labeled \'Revised Manuscript with Track Changes\'.An unmarked version of your revised paper without tracked changes. This file should be uploaded as separate file and labeled \'Manuscript\'.

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

We look forward to receiving your revised manuscript!

Sincerely,

R. Martin Roop II, Ph.D.

Academic Editor

PLOS ONE

\[Note: HTML markup is below. Please do not edit.\]

Reviewers\' comments:

Reviewer\'s Responses to Questions

**Comments to the Author**

1\. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the "Comments to the Author" section, enter your conflict of interest statement in the "Confidential to Editor" section, and submit your \"Accept\" recommendation.

Reviewer \#1: (No Response)

Reviewer \#2: All comments have been addressed

\*\*\*\*\*\*\*\*\*\*

2\. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

3\. Has the statistical analysis been performed appropriately and rigorously?

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

4\. Have the authors made all data underlying the findings in their manuscript fully available?

The [PLOS Data policy](http://www.plosone.org/static/policies.action#sharing) requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data---e.g. participant privacy or use of data from a third party---those must be specified.

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

5\. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

6\. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer \#1: Almost all comments have been addressed adequately. I have only one remaining issue. In the abstract the authors state that BrrF is a \"Fur-regulated small RNA\" (line 27), but as indicated by the other reviewer in the first review Fur-regulation of BrrF is not directly determined for B. ceenocepacia BrrF. This is a reasonable assumption as all data are consistent with this model, but the language in the abstract needs to be modified to remove the certainty.

Reviewer \#2: The authors have adequately addressed the comments from the reviewers, and overall, the work is sound.

However, I would like to encourage the authors to seriously assess their use of qRT-PCR for sRNA levels. I am still not entirely convinced that the qRT-PCR data is accurately depicting the levels of BrrF under different conditions and in different strains. The rebuttal from the authors includes the comment that \"our no-RT controls showed that primers for BrrF

always give signals in this order of magnitude.\" Does this not concern you that the primers you are using are not efficient and/or not reliable? I really am trying to be helpful, as I just want to make sure that the data are as accurate as possible. I would suggest that the authors consider employing northern blot analyses as they continue to work in the area of sRNAs. This will only serve to complement your qRT-PCR results, and it will significantly enhance your ability to analyze smaller differences in sRNA levels.

\*\*\*\*\*\*\*\*\*\*

7\. PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

**Do you want your identity to be public for this peer review?** For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).

Reviewer \#1: No

Reviewer \#2: No

\[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link \"View Attachments\". If this link does not appear, there are no attachment files to be viewed.\]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <https://pacev2.apexcovantage.com/>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at <figures@plos.org>. Please note that Supporting Information files do not need this step.
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Reviewer \#1: Almost all comments have been addressed adequately. I have only one remaining issue. In the abstract the authors state that BrrF is a \"Fur-regulated small RNA\" (line 27), but as indicated by the other reviewer in the first review Fur-regulation of BrrF is not directly determined for B. ceenocepacia BrrF. This is a reasonable assumption as all data are consistent with this model, but the language in the abstract needs to be modified to remove the certainty.

Response:

We have changed the wording of the abstract to "BrrF is a small RNA highly upregulated in Burkholderia cenocepacia under conditions of iron depletion and with a genome context consistent with Fur regulation." (lines 27-28). We also softened the related statement in lines 307-8 in the main manuscript by changing the wording.

Reviewer \#2: The authors have adequately addressed the comments from the reviewers, and overall, the work is sound.

However, I would like to encourage the authors to seriously assess their use of qRT-PCR for sRNA levels. I am still not entirely convinced that the qRT-PCR data is accurately depicting the levels of BrrF under different conditions and in different strains. The rebuttal from the authors includes the comment that \"our no-RT controls showed that primers for BrrF always give signals in this order of magnitude.\" Does this not concern you that the primers you are using are not efficient and/or not reliable? I really am trying to be helpful, as I just want to make sure that the data are as accurate as possible. I would suggest that the authors consider employing northern blot analyses as they continue to work in the area of sRNAs. This will only serve to complement your qRT-PCR results, and it will significantly enhance your ability to analyze smaller differences in sRNA levels.

Response:

We performed Northern blotting for a previous publication (DOI:10.1038/s41598-017-15818-3), using DIG labelled probes and eventually exposing our hybridised membranes to X-ray film. Our lab does not have the setup nor permission for working with radioactively labelled probes. Accurate quantification of the expression levels of BrrF is to our knowledge not possible with that method, because black lines on exposed X-ray film would have to be analysed (please refer to the supplementary material of the publication <https://static-content.springer.com/esm/art%3A10.1038%2Fs41598-017-15818-3/MediaObjects/41598_2017_15818_MOESM1_ESM.pdf>). Northern blotting with this method will probaby be no improvement on qPCR. On the other hand, qPCR, although not perfect, is to our knowledge sufficient to show overexpression of sRNA.

The exact level of overexpression of BrrF from the vectors is dependent on the rhamnose concentration in the medium, and is by definition very similar for all constructs. Exactly replicating the BrrF expression level of wild type cells under iron depletion is not necessary for the purpose of showing that complementation does happen. The purpose of the qPCR experiments in this manuscript is monitoring the changes in levels of putative target mRNAs, and prove that those levels are declining upon BrrF overexpression. The exact fold changes were not subject of further interpretation.

We therefore feel that the additional work and cost involved in setting up Northern blotting experiments is not justified.
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Dear Dr. Sass,

We're pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you'll receive an e-mail detailing the required amendments. When these have been addressed, you'll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at <http://www.editorialmanager.com/pone/>, click the \'Update My Information\' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at <authorbilling@plos.org>.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they'll be preparing press materials, please inform our press team as soon as possible \-- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact <onepress@plos.org>.

Sincerely,

R. Martin Roop II, Ph.D.

Academic Editor

PLOS ONE
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Low iron-induced small RNA BrrF regulates central metabolism and oxidative stress responses in *Burkholderia cenocepacia*

Dear Dr. Sass:

I\'m pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they\'ll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact <onepress@plos.org>.

If we can help with anything else, please email us at <plosone@plos.org>.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Roy Martin Roop II

Academic Editor

PLOS ONE
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